Blood thinner warfarin no longer recommended for most atrial fibrillation cases - (CNN via NewsPoints Desk)

  • New guidance released by the American College of Cardiology and American Heart Association no longer recommends warfarin for most patients with atrial fibrillation, CNN reported Monday.

  • The new guidelines prioritise the use of novel oral anticoagulants (NOACs) such as Eliquis, Pradaxa, Savaysa and Xarelto.

  • The guidelines additionally recommend starting anticoagulants at lower stages of disease and focusing on lifestyle changes such as weight reduction.

  • "In 2014, we recommended the use of warfarin and NOACs, but we didn't prioritise one over the other," explained University of Wisconsin cardiologist Craig January, adding "we are now saying that in some patients, NOACs are better than warfarin."

  • Because of the absence of clinical evidence, the guidelines continue to recommend warfarin for patients with mechanical heart valves and moderate to severe mitral stenosis.

  • "NOACS are better at preventing stroke and have fewer side effects," January noted, continuing "NOACs are not free of side effects, but compared to warfarin, [they're] easier to manage."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.